Latest News Archive

Please select Category, Year, and then Month to display items

Four universities to walk 200 000 km in ten weeks

12 April 2019 | Story Valentino Ndaba | Photo Charl Devenish

“May the best team win the 2019 BestMed Pedometer Challenge!” said LJ van Zyl, Pedometer Challenge ambassador.

Participants in the 2019 BestMed Pedometer Challenge will start improving their health step by step after the University of the Free State (UFS) challenged the Stellenbosch University, Central University of Technology, and North-West University (NWU) to an eight-week walking competition.

South African 400-metre hurdles record-holder and the Pedometer Challenge ambassador, LJ van Zyl, embraced the initiative as an alternative method to achieve fitness. “I am so tired of running and this is great way to stay fit,” he said during the official launch on the UFS Bloemfontein Campus on 5 April 2019.

Inter-institutional fight for fitness

Last year, the UFS Division for Organisational Development and Employment Wellness in the Department of Human Resources led a UFS-only challenge that saw 60 teams of staff members log a total of 54 606 km in eight weeks. The division then challenged the NWU.

Together, the NWU and UFS walked 132 000 km. This year, the UFS is taking it one step further by challenging two more institutions.

Leading the way

“We aim to get South Africa active – starting with the UFS – by embracing fitness and health ourselves,” said Arina Engelbrecht, UFS Employee Wellness Specialist.

Participants on all fitness and activity levels will gun for a 200 000 km target over 10 weeks.

The challenge kicked off on the Bloemfontein Campus with a 3-km walk at the launch, leaving 199 997 km between the four universities for the rest of the eight-week challenge.

News Archive

Nano research at the UFS opens door to smart drugs

2011-06-27

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences.

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.

Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).

Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.

These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept